• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe.

作者信息

Workneh Meklit, Wang Frances, Romagnoli Mark, Simner Patricia J, Carroll Karen

机构信息

Division of Infectious Diseases, Department of Internal Medicine, Johns Hopkins School of Medicine, 1830 East Monument Street, Room 448, Baltimore, MD 21287, USA.

Johns Hopkins School of Medicine, Baltimore, MD, USA.

出版信息

Anaerobe. 2016 Dec;42:98-100. doi: 10.1016/j.anaerobe.2016.09.005. Epub 2016 Sep 28.

DOI:10.1016/j.anaerobe.2016.09.005
PMID:27693544
Abstract

We report a case of bypass graft infection and bacteremia caused by Anaerostipes caccae. A review of the literature shows no reported human infection caused by this microorganism to date. The patient was initially treated with vancomycin and piperacillin-tazobactam on admission and with amoxicillin-clavulanate upon discharge. The slow-growing organism was subsequently found to be susceptible to metronidazole and ertapenem.

摘要

相似文献

1
Bypass graft infection and bacteremia caused by Anaerostipes caccae: First report of human infection caused by a recently described gut anaerobe.
Anaerobe. 2016 Dec;42:98-100. doi: 10.1016/j.anaerobe.2016.09.005. Epub 2016 Sep 28.
2
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.肠球菌引起的外科感染:厄他培南与哌拉西林-他唑巴坦治疗患者的结局
Surg Infect (Larchmt). 2002 Winter;3(4):337-49. doi: 10.1089/109629602762539553.
3
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.厄他培南与哌拉西林/他唑巴坦治疗复杂性腹腔内感染:一项双盲、随机对照III期试验的结果
Ann Surg. 2003 Feb;237(2):235-45. doi: 10.1097/01.SLA.0000048551.32606.73.
4
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.厄他培南与哌拉西林-他唑巴坦治疗混合性厌氧性复杂性腹腔内感染、复杂性皮肤及皮肤结构感染和急性盆腔感染的比较
Surg Infect (Larchmt). 2002 Winter;3(4):303-14. doi: 10.1089/109629602762539535.
5
Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance.厄他培南与哌拉西林/他唑巴坦治疗考虑抗生素耐药的复杂性腹腔内感染的成本-效果评价。
Value Health. 2009 Mar-Apr;12(2):234-44. doi: 10.1111/j.1524-4733.2008.00439.x.
6
Can we really use ß-lactam/ß-lactam inhibitor combinations for the treatment of infections caused by extended-spectrum ß-lactamase-producing bacteria?我们真的可以使用β-内酰胺类/β-内酰胺酶抑制剂联合制剂来治疗由产超广谱β-内酰胺酶细菌引起的感染吗?
Clin Infect Dis. 2012 Jan 15;54(2):175-7. doi: 10.1093/cid/cir793. Epub 2011 Nov 4.
7
Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections.莫西沙星与哌拉西林-他唑巴坦及阿莫西林-克拉维酸治疗复杂性腹腔内感染的随机对照试验
Ann Surg. 2006 Aug;244(2):204-11. doi: 10.1097/01.sla.0000230024.84190.a8.
8
Comparative activity of ertapenem and piperacillin tazobactam in a murine systemic infection model with Bacteroides fragilis and Escherichia coli.厄他培南与哌拉西林他唑巴坦在脆弱拟杆菌和大肠杆菌所致小鼠全身感染模型中的活性比较
J Med Microbiol. 2007 Nov;56(Pt 11):1576-1579. doi: 10.1099/jmm.0.47486-0.
9
Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.厄他培南与哌拉西林-他唑巴坦治疗需要手术干预的腹腔内感染的疗效与安全性比较
J Gastrointest Surg. 2006 Apr;10(4):567-74. doi: 10.1016/j.gassur.2005.06.015.
10
[Controlled, open, parallel-group study of the clinical and microbiological efficacy of piperacillin-tazobactam versus metronidazole + gentamicin in urgent colorectal surgery].哌拉西林-他唑巴坦与甲硝唑+庆大霉素在急诊结直肠手术中临床及微生物学疗效的对照、开放、平行组研究
Cir Esp. 2006 Jun;79(6):365-9. doi: 10.1016/s0009-739x(06)70892-2.

引用本文的文献

1
Diversity and prevalence of in the human gut microbiota.人类肠道微生物群中的多样性和流行情况。 需注意,你提供的原文“Diversity and prevalence of in the human gut microbiota.”中“of”后面缺少具体内容,我是按照合理推测进行翻译的。
bioRxiv. 2025 May 1:2025.05.01.651700. doi: 10.1101/2025.05.01.651700.
2
Mechanistic insight of neurodegeneration due to micro/nano-plastic-induced gut dysbiosis.微/纳米塑料诱导的肠道菌群失调导致神经退行性变的机制洞察
Arch Toxicol. 2025 Jan;99(1):83-101. doi: 10.1007/s00204-024-03875-3. Epub 2024 Oct 6.
3
Effects of Fumonisin B and Hydrolyzed Fumonisin B on Growth and Intestinal Microbiota in Broilers.
伏马菌素 B 和水解伏马菌素 B 对肉鸡生长和肠道微生物群的影响。
Toxins (Basel). 2022 Feb 23;14(3):163. doi: 10.3390/toxins14030163.
4
Biographical Feature: Karen C. Carroll, M.D.人物特写:医学博士凯伦·C·卡罗尔
J Clin Microbiol. 2021 Jul 19;59(8):e0065121. doi: 10.1128/JCM.00651-21.
5
Gastrointestinal surgery and the gut microbiome: a systematic literature review.胃肠外科学与肠道微生物组:系统文献综述。
Eur J Clin Nutr. 2021 Jan;75(1):12-25. doi: 10.1038/s41430-020-0681-9. Epub 2020 Jul 13.